163 related articles for article (PubMed ID: 19901964)
21. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
Luparello C; Sirchia R; Pupello D
J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
[TBL] [Abstract][Full Text] [Related]
22. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
[TBL] [Abstract][Full Text] [Related]
23. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
[TBL] [Abstract][Full Text] [Related]
24. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
25. Cadherin-11 is expressed in invasive breast cancer cell lines.
Pishvaian MJ; Feltes CM; Thompson P; Bussemakers MJ; Schalken JA; Byers SW
Cancer Res; 1999 Feb; 59(4):947-52. PubMed ID: 10029089
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
[TBL] [Abstract][Full Text] [Related]
27. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
28. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding.
De Wever O; Westbroek W; Verloes A; Bloemen N; Bracke M; Gespach C; Bruyneel E; Mareel M
J Cell Sci; 2004 Sep; 117(Pt 20):4691-703. PubMed ID: 15331629
[TBL] [Abstract][Full Text] [Related]
29. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
30. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation.
Albergaria A; Ribeiro AS; Pinho S; Milanezi F; Carneiro V; Sousa B; Sousa S; Oliveira C; Machado JC; Seruca R; Paredes J; Schmitt F
Hum Mol Genet; 2010 Jul; 19(13):2554-66. PubMed ID: 20385540
[TBL] [Abstract][Full Text] [Related]
31. Notch1 is involved in migration and invasion of human breast cancer cells.
Wang J; Fu L; Gu F; Ma Y
Oncol Rep; 2011 Nov; 26(5):1295-303. PubMed ID: 21785827
[TBL] [Abstract][Full Text] [Related]
32. The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models.
Bernardes N; Ribeiro AS; Abreu S; Mota B; Matos RG; Arraiano CM; Seruca R; Paredes J; Fialho AM
PLoS One; 2013; 8(7):e69023. PubMed ID: 23894398
[TBL] [Abstract][Full Text] [Related]
33. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro.
Gao MQ; Kim BG; Kang S; Choi YP; Park H; Kang KS; Cho NH
J Cell Sci; 2010 Oct; 123(Pt 20):3507-14. PubMed ID: 20841377
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
van Horssen R; Hollestelle A; Rens JA; Eggermont AM; Schutte M; Ten Hagen TL
Breast Cancer Res Treat; 2012 Nov; 136(2):365-77. PubMed ID: 23053649
[TBL] [Abstract][Full Text] [Related]
35. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
[TBL] [Abstract][Full Text] [Related]
36. Increased soluble E-cadherin in melanoma patients.
Billion K; Ibrahim H; Mauch C; Niessen CM
Skin Pharmacol Physiol; 2006; 19(2):65-70. PubMed ID: 16685144
[TBL] [Abstract][Full Text] [Related]
37. ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner.
Zhou Y; Ming J; Xu Y; Zhang Y; Jiang J
Biochem Biophys Res Commun; 2015 Feb; 457(2):141-7. PubMed ID: 25514034
[TBL] [Abstract][Full Text] [Related]
38. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.
Nieman MT; Prudoff RS; Johnson KR; Wheelock MJ
J Cell Biol; 1999 Nov; 147(3):631-44. PubMed ID: 10545506
[TBL] [Abstract][Full Text] [Related]
39. Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.
Dong HM; Liu G; Hou YF; Wu J; Lu JS; Luo JM; Shen ZZ; Shao ZM
J Cancer Res Clin Oncol; 2007 Feb; 133(2):83-92. PubMed ID: 16932944
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of E- and P-cadherin in invasive breast cancer cells.
Sarrió D; Palacios J; Hergueta-Redondo M; Gómez-López G; Cano A; Moreno-Bueno G
BMC Cancer; 2009 Mar; 9():74. PubMed ID: 19257890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
